Raquel Torres
Impact in
-
- Advanced Breast Cancer Therapies
- Oncology top 10%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
-
- Advanced Breast Cancer Therapies 5
- Oncology 5
- Cancer-related Molecular Pathways 5
- HER2/EGFR in Cancer Research 2
- Co-authors
- Marı́a José Lallena (5 shared papers)Alfonso de Dios (4 shared papers)Shufen Cai (2 shared papers)Emiko L. Kreklau (2 shared papers)Rose T. Ajamie (2 shared papers)Philip W. Iversen (1 shared paper)Blake Lee Neubauer (2 shared papers)Lawrence M. Gelbert (2 shared papers)
- Journals
- Cancer Research (3 papers)Investigational New Drugs (1 paper)Developmental Neuroscience (1 paper)Physiological Genomics (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Raquel Torres
8 papers receiving 688 citations
Raquel Torres's Hit Papers
Peers
Comparison fields: 5 of 65
- Pulmonary and Respiratory Medicine 409
- Oncology 319
- Genetics 105
- Cardiology and Cardiovascular Medicine 134
- Endocrinology, Diabetes and Metabolism 72
Countries citing papers authored by Raquel Torres
This map shows the geographic impact of Raquel Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel Torres more than expected).
Fields of papers citing papers by Raquel Torres
This network shows the impact of papers produced by Raquel Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel Torres. The network helps show where Raquel Torres may publish in the future.
Co-authors
The 25 scholars most cited alongside Raquel Torres, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine Hit paper breakdown → | 2014 | 453 |
| 2 | 2006 | 166 | |
| 3 | 2006 | 26 | |
| 4 | 2015 | 22 | |
| 5 | 2011 | 14 | |
| 6 | 2016 | 13 | |
| 7 | 2016 | 5 | |
| 8 | 2016 | 3 | |
| 9 | 2025 | 0 |
About Raquel Torres
Raquel Torres is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cell Biology and Surgery, having authored 9 papers that have together received 702 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (2 papers), Advanced Glycation End Products research (1 paper), Ubiquitin and proteasome pathways (1 paper), Connexins and lens biology (1 paper), Renin-Angiotensin System Studies (1 paper) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (409 citations), Oncology (319 citations), Genetics (105 citations), Cardiology and Cardiovascular Medicine (134 citations) and Endocrinology, Diabetes and Metabolism (72 citations). Raquel Torres has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Marı́a José Lallena, Alfonso de Dios, Shufen Cai, Emiko L. Kreklau, Rose T. Ajamie, Philip W. Iversen, Blake Lee Neubauer, Lawrence M. Gelbert, Concepción Sánchez‐Martínez and Xi Lin. Their work appears in journals such as Cancer Research, Investigational New Drugs, Developmental Neuroscience, Physiological Genomics and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.